99mTc-14 F7 Mab
99mTc-14 F7 Mab Uses, Dosage, Side Effects, Food Interaction and all others data.
99mTc 14F7 Mab has strong anti tumor activity against myeloma cells in vivo. Growth inhibition and prolonged survival of the myeloma tumor were obtained as evidences of anti tumor effect after treatment with 99mTc 14F7 Mab.
| Trade Name | 99mTc-14 F7 Mab |
| Generic | 99mTc-14 F7 Mab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Uses
Investigated for use/treatment in breast cancer.
How 99mTc-14 F7 Mab works
The 99mTc 14F7 Mab has shown to bind specifically to GM3 (NeuGc) and that it also reacts with human breast and melanoma tumors in contrast with its low reactivity in normal tissues. N-Glycolyl GM3 is considered a heterophilic antigen since is not present in all species, humans are normally lacking them. The discovery of the presence of this molecule in significant amounts in breast tumors allowed considering it as an advantageous target for cancer immunotherapy.
Innovators Monograph
You find simplified version here 99mTc-14 F7 Mab
